Asp Isotopes Inc. (ASPI) Stock Price & Analysis
Asp Isotopes Inc. (ASPI) fell 4.21% to USD 3.87 as of July 25, 2026 at 17:07 UTC, according to Nexqual real-time market data.
ASPI last closed at USD 4.04; the session ranged USD 3.87–4.07 on volume of 2,571,674 shares. Market capitalization is $487.25M, with a 52-week range of USD 3.61–14.49 (NCM). Source: Nexqual, July 25, 2026 at 17:07 UTC.
Key Statistics (as of July 25, 2026 at 17:07 UTC)
| Price | USD 3.87 |
|---|---|
| Change | ▼ 4.21% (down) |
| Previous Close | USD 4.04 |
| Open | USD 4.07 |
| Day Range | USD 3.87 – 4.07 |
| 52-Week Range | USD 3.61 – 14.49 |
| Volume | 2,571,674 shares |
| Market Cap | $487.25M |
| Exchange | NCM |
Technical Analysis (ASPI)
Nexqual's technical model rates ASPI "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 17:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.17 (oversold) |
| vs SMA50 | Below (USD 5.93) |
| MACD | -0.62 (negative) |
Analyst Ratings (ASPI)
Wall Street analysts rate ASPI "None" based on 3 analysts, with a mean price target of USD 13 (range USD 11–15), per Nexqual as of July 25, 2026 at 17:07 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 13 |
| High Target | USD 15 |
| Low Target | USD 11 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (ASPI)
| Next Earnings Date | 2026-08-14 |
|---|---|
| EPS Estimate | USD -0.39 |
| Revenue Estimate | $3.45M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.05 vs est -0.28 ▲ beat |
| 2025-12-31 | USD -0.41 vs est -0.14 ▼ miss |
| 2025-09-30 | USD -0.15 vs est -0.1 ▼ miss |
| 2025-06-30 | USD -1.03 vs est -0.11 ▼ miss |
Source: Nexqual, July 25, 2026 at 17:07 UTC.
Financials & Fundamentals (ASPI)
| Total Revenue | $26.93M |
|---|---|
| Revenue Growth (YoY) | +279.30% |
| Gross Margin | +17.62% |
| Operating Margin | -595.41% |
| Profit Margin | +0.00% |
| ROE | -103.32% |
| Debt / Equity | 87.57 |
| Current Ratio | 4.39 |
| Total Cash | $290.52M |
| Total Debt | $261.84M |
| Free Cash Flow | $-39.83M |
Source: Nexqual, July 25, 2026 at 17:07 UTC.
Financial Health Score (ASPI)
Nexqual rates Asp Isotopes Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 17:07 UTC.
| Growth | Strong — Revenue +475% YoY (annual) |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $291M cash vs $262M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$40M, burning cash |
| Efficiency | Critical — ROE -103%, ROA -13.7% |
Ownership (ASPI)
| Insider Ownership | +11.08% |
|---|---|
| Institutional Ownership | +48.57% |
| Shares Outstanding | 125.90M |
| Float | 108.99M |
| Short % of Float | +21.47% |
Source: Nexqual, July 25, 2026 at 17:07 UTC.
Leadership (ASPI)
Asp Isotopes Inc. is led by Paul Elliot Mann C.F.A. (age 48), Executive Chairman & CEO, per Nexqual as of July 25, 2026 at 17:07 UTC.
| Executive Chairman & CEO | Paul Elliot Mann C.F.A. (age 48) |
|---|---|
| Chief Financial Officer | Heather Kiessling (age 60) |
| Chief Operating Officer | Robert Ainscow (age 48) |
| Co-Chief Operating Officer | Nicholas Michael Mitchell (age 45) |
| Chief Technology Officer | Hendrik Strydom B. Sc, M. Sc (age 64) |
Major Backers & Investors (ASPI)
Notable institutional backers of Asp Isotopes Inc. include Encompass Capital Advisors, LLC, Rovida Investment Management Ltd, Exchange Traded Concepts LLC, according to Nexqual as of July 25, 2026 at 17:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Encompass Capital Advisors, LLC | 4.51% |
| Rovida Investment Management Ltd | 2.67% |
| Exchange Traded Concepts LLC | 2.42% |
| UBS Group AG | 1.85% |
| Alyeska Investment Group, L.p. | 1.76% |
| AWM Investment Company, Inc. | 1.39% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.8% |
| Vanguard Group | 6.83% |
| Geode Capital | 1.79% |
| State Street | 1.51% |
Source: Nexqual, July 25, 2026 at 17:07 UTC.
From Asp Isotopes Inc.'s Latest SEC 10-K Filing (filed 2026-04-10)
Key Strengths & Strategy (as disclosed to the SEC)
- Our proprietary enrichment technologies, the Aerodynamic Separation Process ("ASP technology") and Quantum Enrichment technology ("QE technology"), are designed to enable the production of isotopes for a range of industrial and advanced technology applications.
- We plan to begin research and development for the enrichment of uranium to demonstrate our capability to produce HALEU using QE technology.
- We believe we compare favorably with many of our helium competitors due our geographic location near the Cape of Good Hope, which we believe will allow us to provide helium to parts of the world that other competitors, such as companies located in Qatar, cannot.
Partnerships
- On March 29, 2026, QLE entered into a securities exchange agreement with an investor (the "QLE Exchange Agreement").
- Agreements with TerraPower LLC On April 4, 2024, we entered into an agreement with TerraPower to develop a conceptual design, refined cost/schedule/financing, risk register, and term sheet for a HALEU facility (the "TerraPower Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NNE | Nano Nuclear Energy Inc. | USD 15.59 | ▼ 9.99% |
| LTBR | Lightbridge Corporation | USD 7.5 | ▼ 8.31% |
| LEU | Centrus Energy Corp. | USD 163.89 | ▼ 5.96% |
| LAES | SEALSQ Corp | USD 2.43 | ▼ 6.54% |
| EU | enCore Energy Corp. | USD 1.14 | ▼ 5.79% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 17:07 UTC. This page is informational and not investment advice.